Where does NEW York Medical College rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NEW York Medical College ranks #49,050 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NEW York Medical College hold?

NEW York Medical College holds 5 US utility patents granted between 2020 and 2025, spanning 10 technology areas.

What is NEW York Medical College's Innovation Score?

NEW York Medical College has an Innovation Score of 34.1 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NEW York Medical College focus on?

NEW York Medical College's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 4 patents, ranking #4,709 of 7,163 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is NEW York Medical College's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for NEW York Medical College.

What does claim depth mean for NEW York Medical College's patents?

NEW York Medical College's patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NEW York Medical College patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NEW York Medical College

USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, NEW ranks #49,050 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 10 technology areas.

#49,050
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.1/100): 16.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49050 · US Corporation #49,050 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,050/49,997
PHOTO-FINISH Neurohaptics
CPC-FOCUS A61K · 10 areas
INNOV-THIN 34.1/100
CLAIMS-RICH 16.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Neurohaptics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How NEW’s 34.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (18%) Velocity 6.7 pts (20%) Breadth 11.2 pts (33%) Claim depth 10.1 pts (30%)

Qualcomm Incorporated · highest

85
NEW York Medical… · this assignee

34
3D Lighting… · lowest

7

What this shows NEW's Innovation Score is 34.1/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for NEW?

Each dot is one of NEW’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). NEW’s own 16.8 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

NEW vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where NEW's grants concentrate

NEW York Medical College is a focused PatentsView assignee: 10 CPC subclasses with 80% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2022. By volume, NEW sits between Neurohaptics, Inc. and NEXO.

NEW's three-year grant acceleration

NEW York Medical College shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Neurohaptics

5
Neuros

5
NEW Frontier Labs

5
NEW York Life Ins…

5
Newteq Holding B V

5
NEX Medical Antis…

5
Nexgen Composites

5
NEXO

5
NEW York Medical… ◀

5

What this shows NEW holds 5 patents at rank #49,001, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NEW

By rank, the assignees closest to #49,001 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in NEW's primary technology class.

NEW's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

NEW York Medical College patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	40.0%
2022	1	20.0%
2023	1	20.0%
2025partial year	1	20.0%

Which technologies does NEW York Medical College patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C07K - Peptides 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

C07D - Heterocyclic Compounds 1

C07C - Acyclic OR Carbocyclic Compounds 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NEW York Medical College's patent record in context - here's where to go next.

NEW York Medical College's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 80% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #49,050 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NEW York Medical College against Neurohaptics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.